Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

C-reactive protein

  • You have access
    Serum Inflammatory Dynamics as Novel Biomarkers for Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer With Bone Metastases
    YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SATOSHI KATO, SHINJI MIWA, MIHO OKUDA, ISAO MATSUMOTO, SEIJI YANO and SATORU DEMURA
    Anticancer Research October 2024, 44 (10) 4493-4503; DOI: https://doi.org/10.21873/anticanres.17278
  • You have access
    The C-reactive Protein to Prealbumin Ratio Is an Independent Prognostic Factor for Patients With Gastric Cancer Who Receive Curative Surgery
    TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, KEISUKE KOMORI, KAZUKI OTANI, KEISUKE KAZAMA, SHO SAWAZAKI, MASAKATSU NUMATA, NATSUMI KAMIYA, AYA KATO, TAKANOBU YAMADA, SHINSUKE NAGASAWA, SHINNOSUKE KAWAHARA, HARUHIKO CHO, JUNYA MORITA, MIE TANABE, NORIO YUKAWA, AYA SAITO, YASUSHI RINO, TAKASHI OGATA and TAKASHI OSHIMA
    Anticancer Research November 2023, 43 (11) 5181-5187; DOI: https://doi.org/10.21873/anticanres.16719
  • You have access
    Modified Geriatric Nutrition Risk Index as a Prognostic Predictor for Unresectable/Recurrent Esophageal Cancer
    KEITA KOUZU, HIRONORI TSUJIMOTO, NAOYUKI UEHATA, YUSUKE ISHIBASHI, YOJI KISHI and HIDEKI UENO
    Anticancer Research December 2022, 42 (12) 5999-6006; DOI: https://doi.org/10.21873/anticanres.16111
  • You have access
    A Multi-institutional Study to Diagnose the Risk of Lymph Node Metastasis Using a CRP Genetic Polymorphism Test Kit in pT1, cN0 Thoracic Esophageal Squamous Cell Carcinoma
    SATORU MOTOYAMA, MIKI HOSAKA, TAKASHI KAMEI, MASAKI UENO, MASAYUKI WATANABE, YU OHKURA, SHINJI MINE, SHUNSUKE TANABE, TAKAHIRO TOYOKAWA, AKIYUKI WAKITA, KATSUNORI NISHIKAWA, ITASU NINOMIYA, KAZUMA FUJITA, MIE KANDA, MITSUHARU HIRAI, MANAMI HOSHI, SHIH-WEI CHIU, MUNENORI TAKATA, TAKUHIRO YAMAGUCHI and MASATOMO MIURA
    Anticancer Research December 2022, 42 (12) 6105-6112; DOI: https://doi.org/10.21873/anticanres.16123
  • You have access
    Can We Predict a Higher Risk of Urothelial Bladder Cancer With a Simple Blood Test?
    BRENDAN WALLACE, SNIR DEKALO, MHRAN KABHA, ISHAI MINTZ, HAIM MATZKIN and NICOLA J. MABJEESH
    Anticancer Research July 2022, 42 (7) 3569-3573; DOI: https://doi.org/10.21873/anticanres.15843
  • You have access
    Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer
    MOTOHIRO FUJIWARA, RYO FUJIWARA, TETSUYA URASAKI, TOMOHIKO OGUCHI, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, JUNJI YONESE and TAKESHI YUASA
    Anticancer Research April 2022, 42 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.15685
  • You have access
    Elevated Postoperative Levels of Serum C-reactive Protein Are Associated With Shorter Long-term Survival After Resection of Colorectal Liver Metastases, Regardless of the Occurrence of Infectious Complications
    MASATSUNE SHIBUTANI, KENJIRO KIMURA, SHINICHIRO KASHIWAGI, EN WANG, YUKI OKAZAKI, KIYOSHI MAEDA, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research May 2021, 41 (5) 2605-2610; DOI: https://doi.org/10.21873/anticanres.15040
  • You have access
    A High Postoperative Serum C-reactive Protein Level Has a Negative Impact on Long-term Survival, Regardless of Postoperative Infectious Complications, in Patients Who Undergo Laparoscopic Surgery for Colorectal Cancer
    MASATSUNE SHIBUTANI, WANG EN, YUKI OKAZAKI, KIYOSHI MAEDA, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research March 2021, 41 (3) 1593-1598; DOI: https://doi.org/10.21873/anticanres.14920
  • You have access
    Prognostic Significance of Combined Platelet Distribution Width and C-Reactive Protein Score in Esophageal Cancer
    YUTA KAWAKITA, SATORU MOTOYAMA, YUSUKE SATO, AKIYUKI WAKITA, YUSHI NAGAKI, KAZUHIRO IMAI and YOSHIHIRO MINAMIYA
    Anticancer Research October 2020, 40 (10) 5715-5725; DOI: https://doi.org/10.21873/anticanres.14586
  • You have access
    Prognostic Impact of a Novel Tumor Marker and Inflammation Index for Patients With Non-small-cell Lung Cancer
    MASAKI TOMITA, RYO MAEDA, TAKANORI AYABE and KUNIHIDE NAKAMURA
    Anticancer Research July 2020, 40 (7) 4023-4027; DOI: https://doi.org/10.21873/anticanres.14397

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire